<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00496184</url>
  </required_header>
  <id_info>
    <org_study_id>20050989</org_study_id>
    <nct_id>NCT00496184</nct_id>
  </id_info>
  <brief_title>Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis</brief_title>
  <official_title>Topical Application of Nifedipine Cream for the Treatment of Vulvar Vestibulitis Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Galilee Hospital-Nahariya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Western Galilee Hospital-Nahariya</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the use of topical application of Nifedipine cream for the treatment of Provoked
      localized Vulvodynia (vestibulitis, vestibulodynia).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      30 women aged 18-45 diagnosed with Provoked localized Vulvodynia will be included. 10 women
      will use topical Nifedipine cream 0.2% 4 times a day for 6 weeks (except for menstrual
      period). 10 other women will use topical Nifedipine cream 0.4% 4 times a day for 6 weeks
      (except for menstrual period).

      10 women will be a control group and will use a placebo cream. The study will be randomized
      and double blind. Participants will be examined before starting the treatment, at the end of
      the treatment and 3 months after completion the treatment. A special detailed questionnaire
      has been prepared in three languages and will be used to compare dyspareunia and associate
      variables between the groups.

      The Q-tip tests will be performed and findings will be drawn in each examination. Differences
      between the groups will be examined, and uni- and multi-variate analysis will be performed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">May 2008</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete resolution of vestibulitis.</measure>
    <time_frame>Participants will be examined before starting the treatment, at the end of the treatment and 3 months after completion the treatment, using the questionnaire and the Q-tip applicator for detection of vestibular sensitivity.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety of the Nifedipine treatment.</measure>
    <time_frame>Participants will be examined before starting the treatment, at the end of the treatment and 3 months after completion the treatment, using the questionnaire.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Vulvar Diseases</condition>
  <condition>Vulvar Pain</condition>
  <condition>Vestibulitis</condition>
  <condition>Vestibulodynia</condition>
  <condition>Vulvodynia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nifedipine cream topical application</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Women diagnosed with vestibulitis according to Friedrich's criteria:

               -  Severe pain with vestibular touch or attempted vaginal entry.

               -  A positive Q-tip test: pain produced by touching the vestibule with a cotton
                  tipped applicator.

               -  Physical findings limited to varying degree of vestibular erythema.

          2. Non-pregnant women aged 18-45.

          3. Women use effective contraception and are not interested in becoming pregnant during
             the study period.

          4. No known Nifedipine allergy.

          5. No medical diseases.

        Exclusion Criteria:

          1. Women who have undergone vestibulectomy.

          2. Active vaginal or pelvic infection.

          3. A medical disease uch as Diabetes, immune suppression.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob Bornstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Galilee Hospital, Nahariya, Israel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Doron Zarfati, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Galilee Hospital, Nahariya, Israel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Colposcopy Clinic, Obstetrics and Gynecology Department, Western galilee Hospital</name>
      <address>
        <city>Nahariya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology</name>
      <address>
        <city>Nahariya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <reference>
    <citation>Walsh KE, Berman JR, Berman LA, Vierregger K. Safety and efficacy of topical nitroglycerin for treatment of vulvar pain in women with vulvodynia: a pilot study. J Gend Specif Med. 2002 Jul-Aug;5(4):21-7.</citation>
    <PMID>12192883</PMID>
  </reference>
  <reference>
    <citation>Nelson R. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2003;(4):CD003431. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003431.</citation>
    <PMID>14583976</PMID>
  </reference>
  <reference>
    <citation>Bornstein J, Zarfati D, Goldik Z, Abramovici H. Vulvar vestibulitis: physical or psychosexual problem? Obstet Gynecol. 1999 May;93(5 Pt 2):876-80. Review.</citation>
    <PMID>10912437</PMID>
  </reference>
  <verification_date>May 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 2, 2007</study_first_submitted>
  <study_first_submitted_qc>July 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 4, 2007</study_first_posted>
  <last_update_submitted>May 2, 2008</last_update_submitted>
  <last_update_submitted_qc>May 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2008</last_update_posted>
  <keyword>Nifedipine treatment</keyword>
  <keyword>Vestibulitis</keyword>
  <keyword>Placebo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vulvodynia</mesh_term>
    <mesh_term>Vulvar Vestibulitis</mesh_term>
    <mesh_term>Vulvar Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nifedipine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

